Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- befree-2016 importedOn "2016-02-19" NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_assertion wasGeneratedBy ECO_0000203 NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_assertion wasDerivedFrom befree-2016 NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_assertion SIO_000772 22169598 NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_assertion evidence source_evidence_literature NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.
- NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_assertion description "[Our findings also indicate that caution is warranted when directly injecting the TLR9 agonist CpG ODN into glioma tissues as part of glioma immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946616.RAxD0P67FHiwfB0_0Rzcbtaji6i7pbRak_VK7G3azycPs130_provenance.